Neurofisiologia delle malattie neurodegenerative

Condividi su

Gruppo guidato da Filippo Tempia

Neurofisiologia delle malattie neurodegenerative
Eriola Hoxha

Eriola Hoxha

PostDoc fellow

Born in Albania on 26.01.1981. Albanian.

2004. Doctor in Biology (BSc) , University of Padua.

2006. Doctor in Biology, Biomolecular science (MSc), University of Padua.

2011. PhD in Neuroscience (Experimental Neuroscience) supervised by Prof. F. Tempia.

2011 to date: Research fellowship at the Neuroscience Institute Cavalieri Ottolenghi  supervised by Prof. F. Tempia.

Professional Experience and Scholarships:
2004: Research intern. University of Padua, Comparative Endocrinology Laboratory, supervisor Dott.ssa. L. Dalla Valle. Experimental thesis title: “Real-Time PCR assays to quantify Steroidogenic Factor-1 and Steroidogenic Acute Regulatory (StAR) proteins involved in the expression of steroidogenic enzymes in rat.”

2005-2006: Research intern. University of Padua, Pharmacology Laboratory, supervisor Prof. P. Giusti, Pharmacology and Anaesthesiology Department. Experimental thesis title: “Identification and characterization of cerebellar neural precursors which proliferate and differentiate in response to fluoxetine treatment”

2007-2011: PhD student. University of Turin, Department of Neuroscience, section of Physiology and Neuroscience Institute Cavalieri Ottolenghi (NICO), supervised by Prof. Filippo Tempia Experimental thesis title: “Physiological alterations in cerebellar neurodegenerative processes”

Membership in research centers:
Neuroscience Institute Cavalieri Ottolenghi (NICO, Orbassano, Turin);

Field of research:
In vitro electrophysiology, Spinocerebellar ataxia, , murine behavioural tests, Alzheimer’s disease.

News

Microcefalie e Atassie: i risultati delle nostre ricerche presentati alla Convention Telethon

I gruppi di ricerca del prof. Di Cunto e del Prof. Tempia studiano le cause genetiche di microcefalie e atassie.
I loro ultimi studi, realizzati grazie al sostegno di Fondazione Telethon e presentati alla Convention scientifica, aprono la strada a possibili nuovi approcci terapeutici.

15 Marzo 2017